Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia

Human Immunology

Volumn 73, Issue 9, 2012, Pages 920-926

  Peghini, Bethânea Crema ^a   Abdalla, Douglas Reis ^a   Barcelos, Ana Cristina Macedo ^a   Teodoro, Lívia das Graças Vieito Lombardi ^a   Murta, Eddie Fernando Candido ^a   Michelin, Márcia Antoniazi ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CANCER IMMUNOLOGY; CARCINOMA IN SITU; CELLULAR IMMUNITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 TH2 BALANCE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; AGED; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84865357201     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.06.003     Document Type: Article

References (34)

1. Mossmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
2. Josefowicz S.Z., Rudensky A. Control of regulatory T cell lineage commitent and maintenance. Immunity 2009, 30:616-625.
3. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
4. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., Martin B., Wilhelm C., Stockinger B. Transforming growth factor - β 'reprograms' the differentiation of T helper 2 cells and promotes na interleukin 9 producing subset. Nat Immunol 2008, 9:1341-1346.
5. H-2 cells. Nat Immunol 2009, 10:864-871.
6. Hiraoka N., Onozato K., Kosuge T., Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 2006, 12(18):5423-5434.
7. Downey S.G., Klapper J.A., Smith F.O., Yang J.C., Sherry R.M., Royal R.E., Kammula U.S., Hughes M.S., Allen T.E., Levy C.L., Yellin M., Nichol G., White D.E., Steinberg S.M., Rosenberg S.A. Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade. Clin Cancer Res 2007, 13(22):6681-6688.
8. Fecci P.E., Ochiai H., Mitchell D.A., Grossi P.M., Sweeney A.E., Archer G.E., Cummings T., Allison J.P., Bigner D.D., Sampson J.H. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function. Clin Cancer Res 2007, 13(7):2158-2167.
9. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., Zhang Z., Yang H., Zhang H., Zhou C., Yao J., Jin L., Wang H., Yang Y., Fu Y.X., Wang F.S. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132(7):2328-2339.
10. Ho G.Y., Einstein M.H., Romney S.L., Kadish A.S., Abadi M., Mikhail M., Basu J., Thysen B., Reimers L., Palan P.R., Trim S., Soroudi N., Burk R.D. Risk factors for persistent cervical intraepithelial neoplasia Grades 1 and 2: managed by watchful waiting. J Low Genit Tract Dis 2011, 15(4):268-275.
11. Clerici M., Merola M., Ferrario E., Trabattoni D., Villa M.L., Stefanon B., Venzon D.J., Shearer G.M., De Palo G., Clerici E. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997, 89:245-250.
12. Tsukui T., Hildesheim A., Schiffman M.H., Lucci J., Contois D., Lawler P., Rush B.B., Lorincz A.T., Corrigan A., Burk R.D., Qu W., Marshall M.A., Mann D., Carrington M., Clerici M., Shearer G.M., Carbone D.P., Scott D.R., Houghten R.A., Berzofsky J.A. Interleukin - 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res 1996, 56:3967-3974.
13. Tartour E., Gey A., Sastre-Garau X., Lombard Surin I., Mosseri V., Fridman W.H. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 1998, 90(4):287-294.
14. El-Sherif A.M., Seth R., Tighe P.J., Jenkins D. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J Pathol 2001, 195:179-185.
15. Al-Saleh W., Giannini S.L., Jacobs N., Moustchen M., Doyen J., Boniver J., Delvenne P. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol 1998, 184(3):283-290.
16. Tripathy N.K., Chauhan S.K., Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis. Clin Exp Immunol 2004, 138(2):369-374.
17. Zhu J., Paul W.E. CD4 T cells: fates, functions, and faults. Blood 2008, 112(5):1557-1569.
18. Georgiannos S.T., Renaut A., Goode A.W., SheaV M. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. Surgery 2003, 134:827-834.
19. Murphy K.M., Stockinger B. Effector T cell Plasticity: flexibility in the face of changing circumstances. Nat Immunol 2010, 8:674-680.
20. Bais A.G., Beckmann I., Ewing P.C., Eijekemans M.J.C., Meijer C.J., Snijders P.J., Helmerhorst T.J. Cytokine release in HR-HPV (+) women without and with cervical dysplasia (CIN II and III) or Carcinoma, compared with HR-HPV (-) controls. Mediators Inflamm 2007, 2007:1-8.
21. Scott M., Stites D.P., Moscicki A.B. Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diag Lab Immunol 1999, 6:751-755.
22. Kondo S., Sauder D.N. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-α-induced skin inflammation. Eur J Immunol 1997, 27(7):1713-1718.
23. Pardo-Govea T., Callejas D., Núnez-Troconis J., Araujo M., Costa L., Pons H., Delgado M., Monsalve F. Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report. Invest Clin 2005, 46(1):5-13.
24. Rodrigues C.M., Matias B.F., Murta E.F., Michelin M.A. The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells. Clin Med Insights Oncol 2011, 5:107-115.
25. Del Vecchio M., Bajetta E., Canova S., Lotze M., Parmiani A.G., Anichini A. Interleukin-12: Biological properties and clinical application. Clin Cancer Res 2007, 3(16):4677-4685.
26. Bor-Ching S., Rong-Hwa L., Huang-Chun L., Hong-Nerng H.S.M.H., Su-Cheng H. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical. Cancer J Immunol 2001, 167:2972-2978.
27. Mocellin S., Marincola F., Young H.A. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 2005, 78:1043-1051.
28. Zoodsma M., Nolte I.M., Schipper M., Oosterom E., Van Der Steege G., De Vries E.G., Te Meerman G.J., Van Der Zee A.G. Interleukin-10 and Fas polymorphism and susceptibility for (pre) neoplastic cervical disease. Int J Gynecol Cancer 2005, 15(3):282-290.
29. Strauss L., Bergmann C., Whiteside T.L. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer. Int J Cancer 2007, 121(11):2473-2483.
30. Coffey R.J., Bascom C.C., Sipes N.J., Graves-Deal R., Weissman B.E., Moses H.L. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor. Mol Cell Biol 1988, 8:3088-3093.
31. Davidson T.S., Richard J., Dipaolo J., Andersson J., Ethan M., Shevach M. Cutting Edge: IL-2 Is Essential for TGF- mediated induction of Foxp3_ T regulatory cells. J Immunol 2007, 178:4022-4026.
32. Baritaki S., Sifakis S., Huerta-Yepez S., Neonakis I.K., Soufla G., Bonavida B., Spandidos D.A. Over expression of VEGF and TGF-1 m-RNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: Implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol 2007, 31(1):69-79.
33. Chikamatsu K., Sakakura K., Whiteside T.L., Furuya N. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck. Head Neck 2007, 29(2):120-127.
34. Piersma S.J., Welters M.J.P., Van Der Burg S.H. Tumor-specific regulatory T cell in cancer patients. Human Immunol 2008, 69:241-249.